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Abstract
Patients with sickle cell anemia (Hb SS) or sickle cell trait (Hb AS)
may present several types of renal dysfunction; however, comparison
of the prevalence of these abnormalities between these two groups and
correlation with the duration of disease in a large number of patients
have not been thoroughly investigated. In a cross-sectional study using
immunoenzymometric assays to measure tubular proteinuria, microal-
buminuria, measurement of creatinine clearance, urinary osmolality
and analysis of urine sediment, we evaluated glomerular and tubular
renal function in 106 adults and children with Hb SS (N = 66) or Hb
AS (N = 40) with no renal failure (glomerular filtration rate (GFR) >85
ml/min). The percentage of individuals with microalbuminuria was
higher among Hb SS than among Hb AS patients (30 vs 8%, P<0.0001).
The prevalence of microhematuria was similar in both groups (26 vs
30%, respectively). Increased urinary levels of retinol-binding protein
or ß2-microglobulin were detected in only 3 Hb SS and 2 Hb AS
patients. Urinary osmolality was reduced in patients with Hb SS or
with Hb AS; however, it was particularly evident in Hb SS patients
older than 15 years (median = 393 mOsm/kg, range = 366-469)
compared with Hb AS patients (median = 541 mOsm/kg, range = 406-
722). Thus, in addition to the frequently reported early reduction of
urinary osmolality and increased GFR, nondysmorphic hematuria was
found in 26 and 30% of patients with Hb SS or Hb AS, respectively.
Microalbuminuria is an important marker of glomerular injury in
patients with Hb SS and may also be demonstrated in some Hb AS
individuals. Significant proximal tubular dysfunction is not a common
feature in Hb SS and Hb AS population at this stage of the disease (i.e.,
GFR >85 ml/min).
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Introduction
The kidney of the homozygous sickle cell
anemia (Hb SS) patient is affected by the
hemodynamic changes of chronic anemia
and by the consequences of vaso-occlusion,
especially in the renal medulla (1,2). The
disruption of distal nephron and medullary
function leads to a reduction of renal concen-
trating capacity, urinary acidification, and to
impaired potassium metabolism which are
often observed in these patients (3,4). In
contrast, glomerular function is usually well
maintained. In children and young adults the
glomerular filtration rate (GFR) exceeds the
normal value; however, there is a gradual
decrease in GRF which may result in chronic
renal failure associated or not with glomeru-
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lar changes. The contribution of the deterio-
rating glomerular function to morbidity and
mortality in older patients has not been widely
recognized (5,6). Proteinuria has been de-
scribed alone or in association with renal
vein thrombosis, hematuria, leg ulcers, acute
or chronic glomerulonephritis, and the other
components of the nephrotic syndrome (6).
The prevalence rate of proteinuria in pa-
tients with Hb SS has been reported to vary
from 17 to 33% in studies in which protein-
uria was determined by the dipstick method
(7). While asymptomatic and relatively com-
mon, proteinuria seems to be associated with
reduced creatinine clearance in Hb SS pa-
tients older than 40 years.
In the present study we determined the
prevalence of early glomerular and proximal
tubular dysfunction in individuals with ei-
ther Hb SS or sickle cell trait (Hb AS). In
addition, the possible correlation between
renal dysfunction and duration of disease
was investigated.
Subjects and Methods
A cross-sectional study was conducted
on 106 individuals, 66 patients with docu-
mented Hb SS (median age: 22 years (2 to 49
years)) and 40 individuals with Hb AS (me-
dian age: 28 years (5 to 69 years)). All sub-
jects were followed at the Hematology Serv-
ice of Escola Paulista de Medicina and
Faculdade de Ciências Médicas da Santa
Casa de Misericórdia, São Paulo, SP, Brazil.
The exclusion criteria were: documented
acute or chronic infection, painful crisis, or
hemodynamic instability. The presence of
infection was assessed by medical history,
clinical examination and, when indicated,
laboratory tests such as complete blood count,
urinalysis (urine cultures were usually done
if there was leucocyturia >10,000 cells/mm3),
blood cultures, chest X ray, abdominal ultra-
sonography, etc. The diagnosis of Hb SS or
Hb AS was based on clinical features, family
history, and laboratory investigation. Labo-
ratory techniques included hemoglobin e-
lectrophoresis on cellulose acetate, pH 8.9,
and on agar gel, pH 6.2 (8), the solubility test
(9), and the estimation of both Hb F (10) and
Hb A2 (8). The individuals with Hb AS were
either parents or siblings of the patients with
Hb SS included in the study.
Total protein in urine was measured by
the biuret method (11) and the level of serum
creatinine was determined by the Jaffé reac-
tion (12). Creatinine clearance determina-
tions were based on 24-h urine collection
and were calculated as follows: (urine crea-
tinine x 24-h urine volume)/plasma creati-
nine. Patients were carefully instructed on
how to collect urine at home and bring it to
the laboratory at the end of the procedure.
All creatinine clearance results were adjusted
for body surface area (1.73 m2). The level of
ß2-microglobulin in serum or urine was de-
termined using a commercially available kit
(Enzygnost ß2-microglobulin, Behring Insti-
tute, Mannheim, Germany, upper normal
limit = 200 µg/l). A monoclonal antibody-
based immunoenzymometric assay was used
to determine urinary retinol-binding protein
(RBP, upper normal limit = 400 µg/l) (13).
Microalbuminuria was quantitated by ELISA
(upper normal limit = 20 mg/l). Urinary os-
molality was measured by the freezing point
depression method using a 3W2 osmometer
(Advanced Instruments Inc., Needham
Heights, MA). ß2-Microglobulin, RBP, mi-
croalbuminuria and urinary osmolality (after
12-16 h dehydration) were determined in
urine samples. Previous studies from our
institution have shown an excellent correla-
tion between urinary RBP (or ß2-microglobu-
lin) expressed as µg/l and the respective
values corrected for urinary creatinine, when
renal function is preserved, as was the case
for the present patients (13). We preferred to
express the results of these parameters as µg/
l. Hematuria was defined as the presence of
8 or more red blood cells per high power
microscopic field in the urine sediment. If
there was hematuria, an evaluation of eryth-
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rocyte morphology was carried out using
phase contrast microscopy.
Statistical analyses
Statistical analyses were performed us-
ing nonparametric methods. The Mann-
Whitney test was used for the comparison of
continuous variables, while the chi-square
test was used for the comparison of categori-
cal variables, with the level of significance
set at 0.05 (two-tailed).
Results
Table 1 summarizes the laboratory re-
sults obtained for the two groups of indi-
viduals. Hb SS patients had a significantly
lower level of serum creatinine and urinary
osmolality than Hb AS individuals. In con-
trast, patients with Hb SS showed a signifi-
cantly higher level of creatinine clearance,
microalbuminuria, and serum ß2-microglobu-
lin than individuals with Hb AS.
The percentage of individuals with mi-
croalbuminuria was significantly higher in
Hb SS than Hb AS patients (30 vs 8%,
P<0.0001). However, the presence of hema-
turia was quite similar in both groups (26 vs
30%). In the group of patients with Hb AS
we detected one patient showing gross he-
maturia and another having dysmorphic
erythrocytes in the urine.
Seven patients with Hb SS and 2 patients
with Hb AS showed a 24-h total proteinuria
level of 0.2 to 1.0 g, whereas one Hb SS
patient presented 24-h proteinuria of 1.65 g.
None of these patients showed clinical evi-
dence of nephrotic syndrome (edema). In-
creased values of urinary RBP and ß2-micro-
globulin were detected in 1 and 3 patients
with Hb SS, respectively. Two individuals
with Hb AS had increased levels of ß2-mi-
croglobulin, but none had elevated urinary
RBP.
The results of the laboratory parameters
Table 1 - Renal function parameters observed in patients with sickle cell trait (Hb AS) and sickle cell anemia
(Hb SS).
Values are reported as median (range). RBP = Retinol-binding protein; ns = not significant. *8000 cells/field.
Parameter Hb AS Hb SS P Value
Number of patients 40 66 -
Median age (range) (years) 28 (5-69) 22 (2-49) ns
Female/male ratio 32/8 40/26 -
Serum creatinine (mg/dl) 0.70 (0.4-1.1) 0.60 (0.3-1.3) <0.01
Creatinine clearance (ml/min/1.73 m2) 108 (86-212) 118 (87-229) <0.01
Urinary osmolality (mOsm/kg) 567 (333-829) 399 (271-580) <0.001
Microalbuminuria (mg/l) 6.8 (0.8-364.0) 10.5 (0.7-2022.0) <0.05
Number of patients with higher than normal values (%) 3/39 (8) 19/64 (30) <0.0001
Hematuria (cells/field, 400X) 3 (0-80) 3 (0-15) ns
Number of patients with higher than normal values* (%) 12/40 (30) 17/66 (26) ns
Urinary RBP (µg/l) 35 (5-261) 45 (7-462) ns
Number of patients with higher than normal values (%) 0/34 (0) 1/49 (2) ns
Urinary ß2-microglobulin (µg/l) 55 (12-224) 72 (15-761) ns
Number of patients with higher than normal values (%) 2/40 (5) 3/64 (5) ns
Serum ß2-microglobulin (mg/l) 1.39 (0.58-2.59) 1.92 (0.82-3.65) <0.0001
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according to age group for the two groups of
individuals are shown in Table 2. In the Hb
SS group, patients older than 15 years showed
a significantly higher level of serum creati-
nine and microalbuminuria excretion com-
pared to the group of Hb SS patients under
15 years of age. However, Hb SS patients
over 15 years of age showed a significantly
lower urinary osmolality than Hb SS patients
under 15 years. All 19 (49%) Hb SS patients
with microalbuminuria were over 15 years
of age (Figure 1).
In Hb SS patients, the median (range) Hb
F value was similar for subjects with or
without microalbuminuria, i.e., 5.1% (1.8-
8.4) vs 5.3% (0.3-20.3), respectively. In these
subgroups (with or without microalbuminu-
ria), median (range) creatinine clearance was
also not significantly different, i.e., 133 ml/
min (96-169) vs 118 ml/min/1.73 m2 (87-
192), respectively.
Urinary osmolality was reduced in both
patients with Hb SS and with Hb AS, but this
reduction was particularly evident in Hb SS
patients over 15 years of age.
Discussion
In the present study we evaluated the
renal function of a relatively large number of
adults and children with either Hb SS or Hb
AS. It has been reported that patients with
Hb SS may present several types of renal
dysfunction including hyposthenuria, hema-
turia, proteinuria, nephrotic syndrome, aci-
dosis, urinary tract infection, renal failure,
and changes in arterial blood pressure (6).
The inability to concentrate urine appropri-
ately has been the most consistent feature of
sickle cell nephropathy which has been re-
ported to occur in all sickle cell disorders,
including Hb AS (6,14). Typically, adult Hb
SS patients show a maximum urinary con-
centration of about 400 mOsm/kg (15). It has
been suggested that this defect in urinary
concentration can be restored to normal in
very young children with Hb SS submitted to
multiple transfusions of Hb AA erythrocytes
(16). The present data confirm the results
described in previous reports showing an
early and progressive inability to concen-
trate urine in Hb SS which was also present
to a lesser extent in Hb AS individuals. The
generally accepted concept is that the gross
destruction of the vasum rectum system im-
pairs tubular function so that the high medul-
lary interstitial solute concentration neces-
sary for urinary concentration cannot be gen-
Table 2 - Laboratory data of patients with sickle cell trait (Hb AS) and sickle cell anemia (Hb SS) according to age group.
Values are reported as median (range). RBP = Retinol-binding protein; ns = not significant. P values correspond to the comparison between age
groups; #P<0.05; ##P<0.01; *P<0.001; **P<0.0001 for the comparison with the corresponding Hb AS age group (Mann-Whitney test).
Parameter Hb AS Hb SS
≤15 years >15 years P Value ≤15 years >15 years P Value
Number of patients 13 27 27 39
Serum creatinine (mg/dl) 0.60 (0.4-0.8) 0.80 (0.4-1.1) <0.002 0.50# (0.3-0.8) 0.60# (0.4-1.3) <0.001
Creatinine clearance (ml/min/1.73 m2) 103 (97-122) 110 (86-212) ns 114 (87-192) 124## (111-229) ns
Urinary osmolality (mOsm/kg) 607 (333-829) 541 (406-772) ns 419* (365-580) 393** (366-469) <0.001
Microalbuminuria (mg/l) 4.0 (0.8-65.4) 6.8 (0.8-364.0) ns 5.40 (0.7-12.7) 19.3** (1.2-2022) <0.001
Hematuria (cells/field, 400X) 5 (0-80) 3 (0-10) ns 2 (3-10) 4 (1-80) ns
Urinary RBP (µg/l) 43 (5-261) 34 (6-124) ns 37 (7-129) 64 (9-462) <0.05
Urinary ß2-microglobulin (µg/l) 77 (12-224) 52 (17-206) ns 60 (15-167) 81 (15-761) ns
Serum ß2-microglobulin (mg/l) 1.41 (0.85-2.20) 1.35 (0.58-2.59) ns 1.65 (0.83-2.22) 2.02* (0.82-3.65) ns
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erated or maintained (1).
Gross or microscopic hematuria has been
detected, usually involving the left kidney,
and at times severe enough to endanger the
patient’s life or be confused with renal ma-
lignancy (6). In this study, the percentage of
patients with microscopic hematuria was rela-
tively high in both Hb SS and Hb AS groups,
being slightly more frequent in the latter (26
and 30%, respectively). Hematuria was basi-
cally of nonglomerular origin, since only in
one patient did we find dysmorphic urinary
erythrocytes. It has been assumed that hema-
turia is produced by increased sickling of the
erythrocytes in the medulla of the kidney.
This causes sludging of the blood in the
inner medulla with resulting ischemia and
extravasation. At least three factors known
to cause sickling could be operative in the
medulla of the kidney: increased acidity,
hypertonicity and anoxia.
In children with Hb SS, renal function is
characterized by glomerular hyperfiltration
and hyperperfusion but, as early as the sec-
ond decade of life, GFR often declines, de-
spite the persistence of high renal blood flow
rates (17). Chronic renal failure has been
increasingly diagnosed in Hb SS patients
and, in some countries, it is one of the most
common causes of death among Hb SS pa-
tients over 40 years of age (2,18). In the
present study, patients did not have signifi-
cantly reduced GFR. Glomerular hyperfil-
tration (GFR  >140 ml/min) was more com-
monly observed in Hb SS than in Hb AS
individuals.
It has been reported that patients with Hb
SS may present proximal tubule hyperfunc-
tion. In fact, increased proximal tubular re-
absorption of ß2-microglobulin was found in
patients with Hb SS, resulting in elevated
serum levels of the protein. There seems to
be a close relationship between clearance of
ß2-microglobulin and phosphate clearance,
both markers of proximal tubular function
(1,3). In addition, other markers of tubular
dysfunction may be detected in some pa-
tients such as an acidification defect (renal
tubular acidosis), hyperuricemia and hyper-
kalemia (1,3). The great majority of our pa-
tients had urinary ß2-microglobulin and RBP
concentrations within the normal range. Only
3 Hb SS and 2 Hb AS patients had slightly
increased urinary excretion of these micro-
proteins, suggesting that significant proxi-
mal renal injury is quite uncommon in Hb SS
and Hb AS patients.
We were unable to detect any relation-
ship between Hb F levels and microalbumi-
nuria. As we have reported earlier, the Hb F
levels in Brazilian patients with Hb SS is
relatively low (median = 6.7%, range = 0.7-
19.2) to protect against severe systemic com-
plications of the disease (19). The higher
incidence of the CAR/CAR haplotype in our
Hb SS patients could explain the low level of
Hb F observed (20).
We found a high prevalence of microal-
buminuria in Hb SS patients (30%), mainly
in those with a longer duration of disease
(49% in patients older than 15 years). In
some of these patients (N = 8) 24-h total
proteinuria was also increased. In addition,
microalbuminuria was detected in 3 Hb AS
individuals. However, no significant corre-
lation was detected between microalbumi-
nuria and GFR. It is noteworthy that al-
though patients in this cohort had preserved
renal function (creatinine clearance), micro-
albuminuria was detected in many of them.
Possible mechanisms of microalbuminuria
are related to a reduction of ultrafiltration
coefficient and loss of glomerular permse-
lectivity. Microalbuminuria seems to be an
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Figure 1 - Microalbuminuria lev-
els in patients with sickle cell
trait (Hb AS) and sickle cell ane-
mia (Hb SS) according to age.
*P<0.01 for the global compari-
son between Hb AS and Hb SS
groups, and for the comparison
between subgroups over 15
years (Hb AS vs Hb SS) (Mann-
Whitney test).
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early indicator of glomerular injury that could
precede the development of glomeruloscle-
rosis or other types of glomerulonephritis. In
fact, recently, Guasch et al. (17) showed that
when albuminuria is present, the ultrafiltra-
tion coefficient is already diminished even if
GFR is preserved. Therefore, the detection
of microalbuminuria seems to be an impor-
tant marker of glomerular renal injury in
patients with Hb SS.
In conclusion, in this extensive survey of
patients with Hb SS without chronic renal
failure we observed that microalbuminuria
was frequently detected in Hb SS patients
(half of those older than 15 years), and to a
lesser extent in Hb AS individuals. Microhe-
maturia was another common feature in both
groups. Proximal tubular dysfunction was
not a relevant finding.
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